+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Melphalan (CAS 148-82-3) Global Market Research Report 2024 - Product Thumbnail Image

Melphalan (CAS 148-82-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Lonidamine (CAS 50264-69-2) Global Market Research Report 2024 - Product Thumbnail Image

Lonidamine (CAS 50264-69-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Masoprocol (CAS 27686-84-6) Global Market Research Report 2024 - Product Thumbnail Image

Masoprocol (CAS 27686-84-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
Lobaplatin (CAS 135558-11-1) Global Market Research Report 2024 - Product Thumbnail Image

Lobaplatin (CAS 135558-11-1) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Lomustine (CAS 13010-47-4) Global Market Research Report 2024 - Product Thumbnail Image

Lomustine (CAS 13010-47-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Lobenzarit (CAS 63329-53-3) Global Market Research Report 2024 - Product Thumbnail Image

Lobenzarit (CAS 63329-53-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Letrozole (CAS 112809-51-5) Global Market Research Report 2024 - Product Thumbnail Image

Letrozole (CAS 112809-51-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Lapatinib (CAS 231277-92-2) Global Market Research Report 2024 - Product Thumbnail Image

Lapatinib (CAS 231277-92-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Ifosfamide (CAS 3778-73-2) Global Market Research Report 2024 - Product Thumbnail Image

Ifosfamide (CAS 3778-73-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
Gefitinib (CAS 184475-35-2) Global Market Research Report 2024 - Product Thumbnail Image

Gefitinib (CAS 184475-35-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more